US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Braveheart Bio

27.25

-1.6600-5.74%

Post-market: 27.250.00000.00%16:10 EDT

Volume:285.99K

Turnover:7.92M

Market Cap:2.45B

PE:-10.35

High:29.50

Open:28.94

Low:26.47

Close:28.91

52wk High:32.00

52wk Low:24.31

Shares:90.04M

Float Shares:25.83M

Volume Ratio:0.75

T/O Rate:1.11%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.6319

EPS(LYR):-3.9270

ROE:--

ROA:--

PB:-31.30

PE(LYR):-6.94

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Goldman Sachs Remains a Buy on Braveheart Bio, Inc. (BRVE)

Analysts Offer Insights on NA Companies: IMAX (IMAX) and Braveheart Bio, Inc. (BRVE)

Braveheart Bio Q2 EPS $(2.51)

Benzinga Earnings

Earnings Flash (BRVE) Braveheart Bio Posts Q2 Loss $2.51 per Share

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/BRVE"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BRVE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BRVE\",,,,,undefined,":{"symbol":"BRVE","market":"US","secType":"STK","nameCN":"Braveheart Bio","latestPrice":27.25,"timestamp":1789070400000,"preClose":28.91,"halted":0,"volume":285991,"hourTrading":{"tag":"盘后","latestPrice":27.25,"preClose":27.25,"latestTime":"16:10 EDT","volume":4201,"amount":114477.25,"timestamp":1789071008117,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.05741957800069181,"floatShares":25831738,"shares":90039000,"eps":-2.631887,"marketStatus":"Post-Mkt","change":-1.66,"latestTime":"09-10 16:45:38 EDT","open":28.94,"high":29.5,"low":26.47,"amount":7918259,"amplitude":0.104808,"askPrice":27.78,"askSize":72,"bidPrice":26.72,"bidSize":75,"shortable":3,"etf":0,"ttmEps":-2.631887,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":4,"adr":0,"listingDate":1785988800000,"exchange":"NASDAQ","adjPreClose":28.91,"postHourTrading":{"tag":"盘后","latestPrice":27.25,"preClose":27.25,"latestTime":"16:10 EDT","volume":4201,"amount":114477.25,"timestamp":1789071008117,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.745845},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BRVE\",,,,,undefined,":{"symbol":"BRVE","floatShares":25831738,"roa":"--","roe":"--","lyrEps":-3.927011,"volumeRatio":0.745845,"shares":90039000,"dividePrice":0,"high":29.5,"amplitude":0.104808,"preClose":28.91,"low":26.47,"week52Low":24.305,"pbRate":"-31.30","week52High":32,"institutionHeld":0,"latestPrice":27.25,"committee":0.020408,"eps":-2.631887,"divideRate":0,"volume":285991,"delay":0,"ttmEps":-2.631887,"open":28.94,"prevYearClose":18,"prevWeekClose":26.74,"prevMonthClose":25.5,"prevQuarterClose":18,"fiveDayClose":26.95,"twentyDayClose":26.15,"sixtyDayClose":18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BRVE\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BRVE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BRVE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":4,"updateTime":1788926400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BRVE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BRVE","date":"2026-09-09","current":-10.353788,"percent":0.041667,"low":-23.993466,"twenty":-22.21795,"median":-21.930028,"eighty":-20.885512,"high":-12.297967,"avg":-21.137744,"sd":2.55445,"marketCap":1887208084},"quantilePoints":[{"date":"2026-08-07","current":-22.904964,"twenty":-19.277064,"median":-13.835213,"eighty":-12.912865,"marketCap":1837733965},{"date":"2026-08-14","current":-20.770344,"twenty":-22.55018,"median":-20.842324,"eighty":-16.302149,"marketCap":1666466982},{"date":"2026-08-21","current":-21.930028,"twenty":-22.591769,"median":-21.618113,"eighty":-20.309669,"marketCap":1759511923},{"date":"2026-08-28","current":-22.281932,"twenty":-22.249941,"median":-22.006007,"eighty":-20.827928,"marketCap":1787746250},{"date":"2026-09-04","current":-21.010278,"twenty":-22.169963,"median":-21.930028,"eighty":-20.827928,"marketCap":1685717659},{"date":"2026-09-09","current":-23.521594,"twenty":-22.21795,"median":-21.930028,"eighty":-20.885512,"marketCap":1887208084}],"updateTime":1789073138852},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BRVE\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666538872","title":"Goldman Sachs Remains a Buy on Braveheart Bio, Inc. (BRVE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666538872","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666538872?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:55","pubTimestamp":1788954946,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Salveen Richter maintained a Buy rating on Braveheart Bio, Inc. yesterday and set a price target of $48.00. The company’s sha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/goldman-sachs-remains-a-buy-on-braveheart-bio-inc-brve-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/goldman-sachs-remains-a-buy-on-braveheart-bio-inc-brve-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0251142724.SGD","BK4007","BK4550","LU2237443549.SGD","LU2237443895.HKD","LU0868494617.USD","LU0942090050.USD","BK4588","LU1804176565.USD","IE00BFXG1179.USD","LU1894683264.USD","LU1868837136.USD","LU0345770993.USD","IE00B19Z3581.USD","LU1868836591.USD","GSX","IE0004091025.USD","LU2237438978.USD","LU0096364046.USD","BRVE","LU2237443622.USD","IE0034235188.USD","LU2471134523.USD","LU2265009873.SGD","LU0048573561.USD","LU0061475181.USD","IE0004086264.USD","LU2750360997.AUD","LU2237443978.SGD","LU1868836914.USD","LU1868836757.USD","LU2896262040.SGD","LU0742534661.SGD","LU2750360641.GBP","LU2237443382.USD","BK4552","LU1894683348.USD","LU0251131958.USD","BK4533","LU0345770308.USD","LU1144417596.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU2471134879.HKD","LU2471134952.CNY","LU1668664300.SGD","BK4504","LU1791807156.HKD","BK4127","LU0210536198.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587784","title":"Analysts Offer Insights on NA Companies: IMAX (IMAX) and Braveheart Bio, Inc. (BRVE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587784","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587784?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:10","pubTimestamp":1788952247,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on IMAX (IMAX) and Braveheart Bio, Inc. (BRVE) with bullish sen...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-imax-imax-and-braveheart-bio-inc-brve-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-imax-imax-and-braveheart-bio-inc-brve-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4141","NA","IMAX","BK4007","BRVE","BK4108"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377403","title":"Braveheart Bio Q2 EPS $(2.51)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377403","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377403?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:37","pubTimestamp":1788899876,"startTime":"0","endTime":"0","summary":"Braveheart Bio (NASDAQ:BRVE) reported quarterly losses of $(2.51) per share which missed the analyst consensus estimate of $0.74 by 439.19 percent. This is a 1692.86 percent decrease over losses of $(0.14) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/09/61673604/braveheart-bio-q2-eps-2-51","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Braveheart Bio Q2 EPS $(2.51)","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BRVE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666773503","title":"Earnings Flash (BRVE) Braveheart Bio Posts Q2 Loss $2.51 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2666773503","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666773503?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:13","pubTimestamp":1788898431,"startTime":"0","endTime":"0","summary":"Earnings Flash (BRVE) Braveheart Bio Posts Q2 Loss $2.51 per Share","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BRVE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":9,"pageCount":1,"totalSize":34,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BRVE\",params:#limit:6,delay:false,,,undefined,":[]}}